90N.F AFYREN SAS EO 1-
- Market cap
- EUR 83.5M
- P/E
- -
- P/B
- 1.15x
- ROE
- -23.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 90N.F undervalued?
Graham numberThe Graham number of AFYREN SAS EO 1- cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
AFYREN SAS EO 1- fundamental analysis
No fundamental analysis for AFYREN SAS EO 1- yet.
AFYREN SAS EO 1- stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About AFYREN SAS EO 1-
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. It offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. The company's products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermont-Ferrand, France.
Full company profileAFYREN SAS EO 1- financial statements
AFYREN SAS EO 1- annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 3.04M | 3.46M | 3.38M | 2.86M | 2.27M |
| Gross Profit | 1.47M | 1.06M | 326K | -174K | -744K |
| Operating Income | -2.30M | -5.44M | -5.94M | -6.08M | -7.15M |
| EBITDA | - | -8.37M | -8.59M | -8.81M | -13.4M |
| Net Income | -3.61M | -9.20M | -9.59M | -9.75M | -14.4M |
| EPS | -0.14 | -0.36 | -0.37 | -0.38 | -0.40 |
| Balance Sheet | |||||
| Total Assets | 93.1M | 84.8M | 70.4M | 58.6M | 67.1M |
| Total Liabilities | 15.3M | 13.8M | 8.63M | 5.86M | 5.04M |
| Shareholders' Equity | 77.9M | 71.0M | 61.8M | 52.7M | 62.1M |
| Cash & Short-term Investments | 67.1M | 62.3M | 49.6M | 33.5M | 35.2M |
| Cash Flow | |||||
| Operating Cash Flow | -2.72M | -3.30M | -5.04M | -5.62M | -5.60M |
| Capital Expenditure | 345K | 531K | 559K | 221K | 194K |
| Free Cash Flow | -3.06M | -3.83M | -5.60M | -5.84M | -5.79M |
| Ratios | |||||
| ROE | -4.6% | -13.0% | -15.5% | -18.5% | -23.1% |
| ROA | -3.9% | -10.8% | -13.6% | -16.7% | -21.4% |
| Net Profit Margin | -118.9% | -266.2% | -283.7% | -340.8% | -632.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
AFYREN SAS EO 1- dividends
AFYREN SAS EO 1- has not paid dividends in the last 5 fiscal years.
Who owns AFYREN SAS EO 1-
- Insiders 58.92%
- Institutions 10.81%
- Public & others 30.27%
- Shares outstanding 38.7M
- Free float 8.85M
AFYREN SAS EO 1- company profile
- Company name
- AFYREN SAS EO 1-
- Ticker
- 90N.F
- ISIN
- FR0014005AC9
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 149
- Fiscal year end
- December
- Address
- 9-11 rue Gutenberg, Clermont-Ferrand, France, 63100
- Phone
- 33 4 73 90 51 16
- Website
- afyren.com
About AFYREN SAS EO 1-
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. It offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. The company's products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermont-Ferrand, France.
AFYREN SAS EO 1- management
9- Mr. Nicolas SordetCo-Founder, CEO & Director
- Mr. Jeremy PessiotCo- Founder, MD & CTO
- Mr. Maxime CordonnierChief Financial Officer
- Mr. Joachim MerzigerC.O.O.
- Mark ReinhardInvestor Relations Manager
- Ms. Caroline PetignyDirector of CSR, Communication & Public Affairs and CSO
- Ms. Lea BassegodaDirector of Human Resources
- M. RousselHead of Fermentation
- A. BostHead of Process